Asthma Clinical Trial
Official title:
Use of a Self-regulation Intervention to Improve Control and Outcomes in Older Adults With Asthma
Asthma in older adults has been overlooked, understudied, and inadequately treated. While
asthma programs targeting the unique needs of children, teenagers, women, minorities, and
other populations have been successfully developed, there are currently none for older
adults. This is particularly distressing as the asthma hospitalization rates, mortality
rates, quality of life, and control are significantly worse in the elderly as compared to
other age groups. It is clear that novel approaches are needed to improve the care in this
population.
The investigators group has been active in the research of asthma in the elderly. The
investigators have analyzed national asthma data sets to look for disparities in older
adults, have conducted qualitative research to determine factors associated with poor control
in the elderly, and have performed a pilot study of a self-regulation intervention which was
able to improve outcomes. The investigators also have over 20 years of experience in asthma
self-regulation interventions and physician communication enhancement for multiple
populations of asthma patients. The investigators will combine these strengths into their
current protocol.
The intervention program will be based on the self-regulation theory of behavior, which will
enhance the participants' ability to self-manage this chronic condition, actively involve the
participant in their own health care management, and produce sustained results. In this
proposal, the investigators will evaluate a self-regulation asthma intervention in a diverse
population of older adults. The intervention will be personalized to the challenges and goals
each individual faces, which will enhance its applicability in different populations. This
intervention will incorporate standard asthma education, complementary techniques for which
older adults have expressed a strong interest, and enhanced communication with each
participant's physician. Asthma specific outcomes will be assessed at 1, 6, and 12 months.
The primary goal of this intervention is to decrease health care utilization (emergency
department, urgent care, hospital, and unscheduled visits) for older adults with asthma. The
investigators will also assess the ability to improve quality of life, asthma symptoms,
asthma control, lung function parameters, self-efficacy, and cost effectiveness.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|